Repligen (RGEN) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $170.26 +1.59%
EPS Growth %: 0.0%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.24, $0.09 better than the analyst estimate of $0.15. Revenue for the quarter came in at $32.5 million versus the consensus estimate of $31.48 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- After an 18% summer selloff in chip stocks, Citi asks what comes next
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
